Business

ACW achieves early screening closure for XanaMIA trial

ACW achieves early screening closure for XanaMIA trial

Actinogen Medical LimitedOctober 19, 20253
ACW achieves early screening closure for XanaMIA trial

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

All Actinogen Medical Limited news →